- Report: #1010714
Report - Rebuttal - Arbitrate
Complaint Review: Mojdeh Nazari
Mojdeh Nazari2144 New York Drive Altadena California Woodland Hills, California United States of America
Mojdeh Nazari Mojdeh Amini Nazari, Mojie Amini, Mojie Amini Nazari Counterfeiter, Fraud, Illegal Export, Money Laundering Woodland Hills, California
A business' first
line of defense
on the Internet.
If your business is
willing to make a
Click here now..
a preliminary injunction have thus far been granted against the defendants. In the suit, Zosma contends that the defendants willfully and knowingly infringed upon Zosmas trademark. Further, Zosma alleges that the defendants manufactured and exported counterfeit goods in such a manner as to circumvent existing U.S. laws.
With assistance from the United States Marshalls office, the seizure order was carried out at five different locations across Southern California. [continued below]....
straight to Iran, via shipper American Export Lines. Further, over 1.2 million units of counterfeit products have apparently been sold, causing Zosma estimated damages in the tens of millions of dollars. These documents, discovered the day before the first hearing on the case, were provided to the Federal Court as additional exhibits to Zosmas lengthy complaint. The scope of the operation runs deeper than originally anticipated by Zosma and their counsel, Mark Vega, of Los Angeles based
Libertas Law Group.
From 2003 to 2008, Pars Med Kish was the exclusive distributor of Zosmas popular Formulated Sciences line of products. In 2009, Amini and Givi claimed that demand had decreased, and pending orders were cancelled. In 2010 Zosma was alerted by an agent of the Iranian Ministry of Health that their product was again on the shelves in Iranian pharmacies. After an extensive two year investigation Zosma discovered the extent of Amini and Givis alleged fraudulent activity. According
to documents found during the U.S. Marshall raid, Amini and Givi moved production of the fish oil product to Canadian pharmaceutical manufacturer Viva Pharmaceuticals. Additionally, these documents showed that Amini and Givi represented that they owned the trademark of Formulated Sciences to Viva, and began to order millions of dollars worth of the counterfeit product. According to the USPTO website, Amini and Givi even went so far as to attempt registration of a slightly
altered Formulated Sciences logo (application number 85496890), which was rejected by the United States Office of Patent and Trademarks.
According to the suit, Zosma believes that the defendants have knowingly and willfully infringed upon Zosmas trademark and good name in order to profit on estimated millions of dollars worth of sales of the counterfeit goods. By moving for a preliminary injunction, Zosma has effectively stopped Pars Med, Amini, and Givi along with Viva Pharmaceuticals and American Export Lines- from continuing to ship the supposed counterfeit products. Furthermore, the Judge granted Zosmas
request to freeze the defendants assets and bank accounts. Although Viva and Amini both contend that they have nothing to do with the operation, they are being represented by the same lawyer, Reza Sina of Sina Law Group, based in Los Angeles, California.
This report was posted on Ripoff Report on 02/07/2013 10:12 PM and is a permanent record located here: http://www.ripoffreport.com/r/Mojdeh-Nazari/Woodland-Hills-California-/Mojdeh-Nazari-Mojdeh-Amini-Nazari-Mojie-Amini-Mojie-Amini-Nazari-Counterfeiter-Fraud-I-1010714. The posting time indicated is Arizona local time. Arizona does not observe daylight savings so the post time may be Mountain or Pacific depending on the time of year.
If you would like to see more Rip-off Reports on this company/individual, search here:Search Tips
In order to assure the best results in your search:
- Keep the name short & simple, and try different variations of the name.
- Do not include ".com", "S", "Inc.", "Corp", or "LLC" at the end of the Company name.
- Use only the first/main part of a name to get best results.
- Only search one name at a time if Company has many AKA's.